Article
Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.
JAMA - 15 Sept 2004
Warner Ellen, Plewes Donald B, Hill Kimberley A, Causer Petrina A, Zubovits Judit T, Jong Roberta A, Cutrara Margaret R, DeBoer Gerrit, Yaffe Martin J, Messner Sandra J, Meschino Wendy S, Piron Cameron A, Narod Steven A
Abstract excerpt
CONTEXT: Current recommendations for women who have a BRCA1 or BRCA2 mutation are to undergo breast surveillance from age 25 years onward with mammography annually and clinical breast examination (CBE) every 6 months; however, many tumors are detected at a relatively advanced stage. Magnetic resonance imaging (MRI) and ultrasound may improve the ability to detect breast cancer at an early stage. OBJECTIVE: To...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.